New publication on the generation of pre-vascularised organoids
The VANGUARD consortium recently published collaborative work in the journal Transplant International on the generation of pre-vascularised organoids. The authors from the University of Geneva and the University of Eastern Piedmont show that pre-vascularized islet organoids exhibit enhanced in vitro function compared to native islets, improved engraftment and accelerated vascularization in vivo in a murine […]
New Publication: Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells
VANGUARD partners from UNIGE have published a new review article on Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells in Stem Cell Reviews and Reports. The article is available open access and can be read here: https://link.springer.com/article/10.1007/s12015-021-10269-w Abstract Inhibiting pro-inflammatory cytokine activity can reverse inflammation mediated dysfunction of islet […]
VANGUARD featured in the Horizon EU magazine
Horizon, the official magazine for EU-funded research and innovation projects, has published an article about emerging treatments against diabetes. It includes an interview of the VANGUARD Coordinator Dr. Ekaterine Berishvili from the University of Geneva and a description of our project. Read the article here: https://horizon-magazine.eu/article/lab-grown-and-do-it-yourself-two-emerging-routes-artificial-pancreas.html
New research on a promising treatment against type 1 diabetes funded by the European Commission
More than 40 million individuals worldwide are affected by type 1 diabetes, which is the most common chronic disease in children and adolescents. Today’s primary treatment for diabetes is insulin therapy, which requires multiple injections every day to control a person’s blood sugar levels. This can potentially lead to chronic complications such as kidney-related issues […]
